U.S. Pharma Stock News

Jin Medical International ( NASDAQ:ZJYL ) First Half 2025 Results Key Financial Results Revenue: US$9.88m (down 6.4...

Walker & Dunlop CEO Willy Walker recently discussed the outlook for potential Federal Reserve rate cuts and the pressing challenges surrounding affordable housing in the U.S. with industry expert Ivy Zelman. The conversation highlighted persistent regulatory and financing obstacles in the affordable housing sector and growing financial pressures on consumers, sparking industry-wide debate about the sustainability of housing demand. We'll explore how the CEO's frank discussion of...

Key Insights Perma-Pipe International Holdings' estimated fair value is US$33.97 based on 2 Stage Free Cash Flow to...

If you are sizing up Williams Companies stock and wondering what your next move should be, you are not alone. Investors have been drawn in by a mix of solid performance and eye-catching numbers that can make even seasoned market-watchers pause and take a closer look. Over the past year, Williams Companies has delivered a total return of nearly 31%. If you zoom out further, the five-year return sits north of 250%. Those are head-turning figures, especially compared to many peers in the energy...

Earlier this month, Eve Holding filed a follow-on equity offering totaling approximately US$1.47 billion, with over 47 million common shares and the same number of depositary receipts set to be listed at a price of US$4.85 per share and US$26.21 per depositary receipt, respectively. Industry analysts recently identified Eve Holding as one of the two leading players in the eVTOL market, emphasizing its US$14 billion order backlog as a major differentiator over competitors. We'll look at how...

SPX Technologies, Inc. recently completed a follow-on equity offering of 2,659,575 shares, raising approximately US$500 million at a price of US$188 per share with a discount of US$7.52 per share. This capital raise follows a comprehensive shelf registration covering common stock, preferred stock, debt securities, and other instruments, indicating potential for further balance sheet flexibility and future financing activities. We'll now examine how this substantial equity financing may...

Thinking about what to do with Regeneron Pharmaceuticals stock right now? You are not alone. With a price tag near $589, and a recent uptick of about 3% over the last month, it is the kind of stock that gives investors something to talk about. Year to date, the story has not been as cheery, with shares sliding nearly 18% and trailing some biotech peers. But when you dig a bit deeper into the fundamentals, the narrative starts to shift from worry to opportunity. Regeneron is not your average...

If you have been following the rollercoaster that is Arm Holdings' stock chart, you are definitely not alone. With the price rallying over 8% in the last 90 days, only to give back roughly 14% in the last month, investors are left wondering if it is time to catch the next upward move or play it safe on the sidelines. Just a year out from its public debut, Arm has seen sentiment swing often and sharply, as hopes for AI-fueled growth continue to encounter tough questions about valuation and...

GE Aerospace recently announced a partnership with Kratos Defense & Security Solutions to jointly develop turbofan propulsion systems for unmanned aircraft, highlighting Kratos' expertise in advanced defense technologies. Industry analysts and funds have also spotlighted Kratos' strong position for future growth, citing its investments in areas such as hypersonic technology and drone engines amid rising global defense spending. We'll assess how the GE Aerospace partnership and Kratos' focus...

If you have been tracking SolarEdge Technologies lately, you know things have been anything but dull. Maybe you are evaluating your own position, or thinking about jumping in for the first time. Either way, the last few months have been packed with action that is hard to ignore. The stock saw a dramatic swing of over 105% in the past quarter and is up nearly 132% year-to-date. While the one-year return is just 19%, that rapid recent climb hints at shifting perceptions around risk, future...

On August 14, 2025, Texas Roadhouse announced several executive and Board changes, including appointing Gerald L. Morgan as Executive Vice Chairman while he continues serving as CEO, expanding responsibilities for key leadership roles, and appointing Hugh J. Carroll to the Board ahead of his planned year-end retirement. These moves highlight a focus on leadership continuity and experience, particularly as the company strengthens its growth strategy and prepares for longer-term succession...

Cadence Bank was recently added to the Zacks Rank #1 (Strong Buy) list after analysts raised their earnings estimates over the past 60 days. This recognition by Zacks, a widely followed stock ranking platform, highlights increased analyst confidence and potential for heightened investor attention to Cadence Bank. We'll examine how Cadence Bank's inclusion on the Zacks Strong Buy list could influence the company’s investment outlook and analyst narrative. This technology could replace...

On August 21, 2025, OUTFRONT Media appointed Nick Brien as permanent CEO and named Michael Barrett and Nicolle Pangis to its Board of Directors, while also announcing a major partnership with the Bay Area Host Committee for Super Bowl LX and the FIFA World Cup. The addition of high-profile experts in advertising technology and the exclusive tie-in with two of the world’s biggest sporting events underscores OUTFRONT’s push to modernize and expand its digital out-of-home offering. We'll...

Recently, Zurn Elkay Water Solutions received a Strong Buy (Zacks Rank #1) rating, with analysts raising their current-year earnings estimate by 6.7% over the past 60 days. This positive analyst sentiment and upward revisions in earnings estimates highlight strengthening expectations for the company's financial outlook and operational performance. To assess the implications of these upward earnings estimate revisions, we'll examine how this development could impact Zurn Elkay's broader...

Stryker Corporation recently reported robust second-quarter 2025 results, citing strong growth in its orthopaedics segment and increasing adoption of the Mako robotic platform. Management also raised full-year sales and earnings guidance, attributing the momentum to operational synergies from recent acquisitions amid ongoing sector challenges. We'll explore how the raised outlook and Mako platform adoption feed into Stryker's long-term growth prospects and investment narrative. This...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

If you’ve been watching BlackRock (BLK) lately, you might have noticed the stock catching a bit more attention with its latest move. The shares perked up about 2% in the most recent session, a jump that has investors once again reconsidering what’s factored into BlackRock’s valuation. There was no headline-grabbing event driving this uptick, which makes the move itself stand out. This is especially true for those trying to figure out whether this is just routine market noise or a subtle...

Coastal Financial (CCB) is back in the spotlight after disappointing the market with its most recent quarterly results. The company missed expectations on both revenues and net interest income. For investors, earnings misses like this can feel like a warning sign or, sometimes, an early clue to a bigger story unfolding beneath the surface. Coastal is already known for making moves in the digital banking and community space, and leadership has recently doubled down by bringing new executive...

Investors may wish to note that the Chief Medical Officer of Voyager Therapeutics, Inc. , Toby Ferguson, recently...

Fortinet (FTNT) shares have jumped almost 3% today, catching many investors’ attention and sparking a flurry of questions about what exactly is driving the action. While there was no major news or headline event specific to the company, sometimes price moves like this can be an early signal. Whether it is a shift in investor sentiment or simply market volatility, days like these often prompt a closer look at what the market is seeing in the stock. If we zoom out, Fortinet has delivered a...

Cathay General Bancorp recently announced that its Board of Directors declared a cash dividend of US$0.34 per common share, payable on September 8, 2025, to shareholders of record as of August 28, 2025. While the dividend announcement highlights Cathay General Bancorp’s steady track record of distributions, broader sector momentum from Federal Reserve policy commentary has been a more influential force in recent market activity. We’ll explore how renewed confidence in the regional banking...

Zoetis (NYSE:ZTS) is back in the spotlight after raising almost $1.85 billion in fresh capital through two new fixed-income offerings, with several global banks brought onboard as co-lead underwriters. For investors watching the animal health leader, this round of senior, unsecured notes is more than a routine capital markets event. It is a clear signal that Zoetis is actively shaping its balance sheet, which raises questions about how the company intends to deploy these funds and whether the...

Earlier this week, Zacks Investment Research highlighted ITT as a top growth stock due to its strong earnings outlook and positive Growth Score, with expectations for its EPS to grow 10.6% this year, outpacing the industry average. A key insight is that recent upward revisions to ITT’s earnings estimates reinforce market confidence in its near-term performance potential. We'll examine how analyst optimism about ITT's earnings growth and favorable estimates may influence the company's overall...

Amneal Pharmaceuticals recently raised its full-year 2025 guidance following strong quarterly performance and announced progress on two Denosumab biosimilar candidates currently under FDA review, with regulatory decisions expected later in 2025. In addition to these operational updates, Amneal strengthened its financial position through debt refinancing and expects to generate net revenue between US$3.0 billion and US$3.1 billion with adjusted EPS in the range of US$0.70 to US$0.75 this...